Status:
UNKNOWN
Comparison of the Application of Lidocaine With Intraperitoneal Bupivacaine in Cesarian Operations Wound Infiltration
Lead Sponsor:
Ataturk University
Conditions:
Postoperative Pain
Cesarean Section
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Postoperative pain control is important to reduce morbidity and mortality, and this becomes even more important after cesarean delivery. Severe postpartum pain is associated with chronic pain, and the...
Detailed Description
COMPARISON OF THE APPLICATION OF LIDOCAINE WITH INTRAPERITONEAL BUPIVACAINE IN CESARIAN OPERATIONS WOUND INFILTRATION: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY. INTRODUCTION The most common...
Eligibility Criteria
Inclusion
- Pregnant women
- 18-50 years
- ASA I-II,
- ≥34th gestational week
Exclusion
- Patients with neuraxial anesthesia contraindications
- Patients allergic to drugs to be used in the study
- BMI\> 35 kg / m2
- Diabetes, preeclampsia, cardiovascular disease, chronic pain and neuropathic pain
- Patients who have been given opioids in operation due to intraoperative pain
- Patients with unsuccessful spinal anesthesia who underwent general anesthesia
- Patients with excessive bleeding during the operation, uterine atony, placement of the drain in the area to be infiltrated
- Patients who do not want spinal anesthesia,
- Cannot understand VAS
- History of drug addiction and psychiatric illness
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04856735
Start Date
October 1 2020
End Date
May 1 2021
Last Update
April 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ataturk University
Erzurum, Turkey (Türkiye), 25100